Pancreatic Cancer Research

ResearcherShiga University of Medical ScienceActive in the last 2 years

Haruki Mori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9143-256X; OpenAlex author ID A5011450668, A5026105894. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 3 papers · 2025: 2 papers · 2026: 2 papers

Papers 11

  1. Painful penile erection as a manifestation of metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12328-025-02278-w↗
  2. Temporary Mesocaval Bypass During Pancreaticoduodenectomy for Pancreatic Cancer With Portal Vein Occlusion: A Case Report. First author DOI 10.21873/anticanres.18419↗
  3. Preoperative Predictive Nomogram (DASINEL Score) for Early Recurrence in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.17737↗
  4. Dynamic changes in tumor blood flow during chemotherapy: Implications in customized treatment for pancreatic cancer. Co-author DOI 10.3892/ol.2025.15325↗
  5. Clinical impact of the prognostic nutritional index and skeletal muscle index for the incompletion of adjuvant chemotherapy for pancreatic cancer. First author DOI 10.1016/j.asjsur.2024.10.151↗
  6. Contribution of Immunoscore to Survival Prediction in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.17277↗
  7. [A Case of Needle Tract Seeding Discovered Three Years after Pancreatic Cancer Surgery and Treated with Local Gastrectomy]. Co-author PMID 39948921↗
  8. Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced … Co-author DOI 10.1007/s10147-021-02066-9↗
  9. A High C-Reactive Protein Level on Postoperative Day 7 Is Associated With Poor Survival of Patients With Pancreatic Ductal Adenocarcinoma After Resection. Co-author DOI 10.1177/00031348211023406↗
  10. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Co-author DOI 10.1245/s10434-019-07891-x↗
  11. Synchronous primary gallbladder and pancreatic cancer associated with congenital biliary dilatation and pancreaticobiliary maljunction. Co-author DOI 10.1186/s40792-017-0388-x↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiromitsu Maehira · 11 shared papers, 2017–2026 · strength 2.20
  2. Masaji Tani · 10 shared papers, 2017–2026 · strength 1.89
  3. Sachiko Kaida · 8 shared papers, 2022–2026 · strength 1.78
  4. Seiya Naito · 1 shared paper, 2024 · strength 0.18
  5. Daiki Yasukawa · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.